JP2005522439A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522439A5
JP2005522439A5 JP2003565977A JP2003565977A JP2005522439A5 JP 2005522439 A5 JP2005522439 A5 JP 2005522439A5 JP 2003565977 A JP2003565977 A JP 2003565977A JP 2003565977 A JP2003565977 A JP 2003565977A JP 2005522439 A5 JP2005522439 A5 JP 2005522439A5
Authority
JP
Japan
Prior art keywords
alkyl
hydroxy
alkylene
alkoxy
alkoxycarbonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003565977A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522439A (ja
JP4428479B2 (ja
Filing date
Publication date
Priority claimed from GB0202755A external-priority patent/GB0202755D0/en
Priority claimed from GB0213285A external-priority patent/GB0213285D0/en
Priority claimed from GB0221459A external-priority patent/GB0221459D0/en
Priority claimed from GB0221460A external-priority patent/GB0221460D0/en
Application filed filed Critical
Priority claimed from PCT/EP2003/001140 external-priority patent/WO2003066603A1/en
Publication of JP2005522439A publication Critical patent/JP2005522439A/ja
Publication of JP2005522439A5 publication Critical patent/JP2005522439A5/ja
Application granted granted Critical
Publication of JP4428479B2 publication Critical patent/JP4428479B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003565977A 2002-02-06 2003-02-05 キナゾリン誘導体およびｃｂアゴニストとしてのその使用 Expired - Fee Related JP4428479B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB0202755.5 2002-02-06
GB0202755A GB0202755D0 (en) 2002-02-06 2002-02-06 Organic compounds
GB0213285A GB0213285D0 (en) 2002-06-10 2002-06-10 Organic compound
GB0213285.0 2002-06-10
GB0221459.1 2002-09-16
GB0221460.9 2002-09-16
GB0221459A GB0221459D0 (en) 2002-09-16 2002-09-16 Organic compound
GB0221460A GB0221460D0 (en) 2002-09-16 2002-09-16 Organic compound
PCT/EP2003/001140 WO2003066603A1 (en) 2002-02-06 2003-02-05 Quinazolinone derivatives and their use as cb agonists

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009012064A Division JP2009149658A (ja) 2002-02-06 2009-01-22 キナゾリン誘導体およびｃｂアゴニストとしてのその使用

Publications (3)

Publication Number Publication Date
JP2005522439A JP2005522439A (ja) 2005-07-28
JP2005522439A5 true JP2005522439A5 (enExample) 2005-12-22
JP4428479B2 JP4428479B2 (ja) 2010-03-10

Family

ID=27739227

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003565977A Expired - Fee Related JP4428479B2 (ja) 2002-02-06 2003-02-05 キナゾリン誘導体およびｃｂアゴニストとしてのその使用
JP2009012064A Pending JP2009149658A (ja) 2002-02-06 2009-01-22 キナゾリン誘導体およびｃｂアゴニストとしてのその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009012064A Pending JP2009149658A (ja) 2002-02-06 2009-01-22 キナゾリン誘導体およびｃｂアゴニストとしてのその使用

Country Status (21)

Country Link
US (2) US20050085493A1 (enExample)
EP (2) EP2319839A1 (enExample)
JP (2) JP4428479B2 (enExample)
KR (1) KR100954626B1 (enExample)
CN (1) CN100579968C (enExample)
AR (1) AR038483A1 (enExample)
AT (1) ATE551329T1 (enExample)
AU (1) AU2003210212A1 (enExample)
BR (1) BR0307461A (enExample)
CA (1) CA2471974C (enExample)
CO (1) CO5601021A2 (enExample)
EC (1) ECSP045219A (enExample)
ES (1) ES2384967T3 (enExample)
MX (1) MXPA04007641A (enExample)
MY (1) MY143958A (enExample)
NO (1) NO328305B1 (enExample)
NZ (1) NZ571615A (enExample)
PE (1) PE20030867A1 (enExample)
PL (1) PL370657A1 (enExample)
TW (1) TW200306839A (enExample)
WO (1) WO2003066603A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0105114A3 (en) 1999-03-17 2002-09-30 Astrazeneca Ab Quinazolinone derivatives, pharmaceutical compositions containing them, their use and process for their preparation
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
GB0324790D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Amide derivatives
CA2544191A1 (en) 2003-11-04 2005-05-26 Merck & Co., Inc. Substituted naphthyridinone derivatives
SE0303491D0 (sv) * 2003-12-19 2003-12-19 Astrazeneca Ab New use VI
CN100506802C (zh) * 2004-06-04 2009-07-01 中国科学院上海药物研究所 一类甲酰肽样受体-1调节剂、其制备方法和用途
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds
JP2009500439A (ja) * 2005-07-11 2009-01-08 ナームローゼ・フエンノートチヤツプ・オルガノン 疼痛の治療のための相乗的組み合わせ（カンナビノイド受容体アゴニスト及びオピオイド受容体アゴニスト）
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2008157500A1 (en) * 2007-06-17 2008-12-24 Kalypsys, Inc. Aminoquinazoline cannabinoid receptor modulators for treatment of disease
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
FR2944013B1 (fr) * 2009-04-07 2011-07-15 Sanofi Aventis Derives de 1-alkyl-cinnolin-4(1h)-one substitues,leur preparation et leur application en therapeutique.
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531510B1 (en) 2010-02-01 2014-07-23 Novartis AG Pyrazolo[5,1b]oxazole derivatives as crf-1 receptor antagonists
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
TW201348235A (zh) 2012-05-03 2013-12-01 Novartis Ag 作爲格瑞啉受體促效劑之３－螺環哌啶衍生物
UY35675A (es) 2013-07-24 2015-02-27 Novartis Ag Derivados sustituidos de quinazolin-4-ona
CN106146414A (zh) * 2016-07-07 2016-11-23 浙江大学 喹唑啉二酮类衍生物及其制备方法和用途
CN106831502A (zh) * 2017-03-13 2017-06-13 苏州市泽宸贸易有限公司 邻硝基苯磺酰氯、其合成方法及应用
CN109796360B (zh) * 2019-01-30 2022-03-18 上海阿拉丁生化科技股份有限公司 一种3-氨基-2-萘甲酸类化合物的制备工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6200M (enExample) 1967-04-18 1968-07-22
DE1803210A1 (de) 1968-10-16 1970-05-14 Troponwerke Dinklage & Co 2-Methyl-3-(3-[4-phenylpiperazinyl-(1)]-2-hydroxypropyl)-chinazolinon-(4) und Verfahren zu seiner Herstellung
JPS5657768A (en) * 1979-10-18 1981-05-20 Masayuki Ishikawa Novel 4-quinazolone derivative substituted by aromatic residue at 3-position
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
JPS57118570A (en) * 1981-01-16 1982-07-23 Masayuki Ishikawa Novel 3-phenyl-4-quinazolone derivative
AU543928B2 (en) * 1981-01-16 1985-05-09 Masayuki Ishikawa 4(311)-quinazolinone derivatives
WO1993023082A1 (en) * 1992-05-13 1993-11-25 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
WO1997029079A1 (en) 1996-02-06 1997-08-14 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
TW200306839A (en) * 2002-02-06 2003-12-01 Novartis Ag Quinazolinone derivatives and their use as CB agonists
SE0303491D0 (sv) 2003-12-19 2003-12-19 Astrazeneca Ab New use VI
GB0413618D0 (en) * 2004-06-17 2004-07-21 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2005522439A5 (enExample)
ES2620446T3 (es) Nuevo compuesto heterocíclico bicíclico
KR100737090B1 (ko) 축합 이미다졸륨 유도체
JP2008513516A5 (enExample)
EP1277738A1 (en) Condensed heteroaryl derivatives
JP2011518190A5 (enExample)
KR20080040046A (ko) 티아졸 유도체
RU2002131885A (ru) Антраниламиды и их применение в качестве лекарственных средств
JP2008526999A5 (enExample)
JP2017538689A5 (enExample)
JP6380777B2 (ja) ＰＩ３Ｋ、ｍＴＯＲ阻害薬としての縮合キノリン化合物
CA2471974A1 (en) Quinazolinone derivatives and their use as cb agonists
ATE357453T1 (de) Comt-inhibitoren
CA2958741C (en) Quinazoline derivatives
RU2007116987A (ru) Новые соединения
WO2002076438A2 (en) Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
CA2491612A1 (en) 4-'7-halo-2-quino(xa-)linyloxy!phenoxy-propionic acid derivatives as antineoplastic agents
AU2018360730A1 (en) Methods of treating elevated plasma cholesterol
CN107849018B (zh) 哌嗪衍生物
WO2003013432A2 (en) Methods of use for novel sulfur containing organic nitrate compounds
KR102636651B1 (ko) 티아졸로피리딘 또는 이의 약학적으로 허용 가능한 염 및 이의 용도
RU2005130992A (ru) Производные сложноэфирных липидов нуклеотидов
WO2015144977A1 (en) Trpa1 modulators
US12428417B2 (en) Inhibitors of macrophage migration inhibitory factor
TW200526205A (en) Nitrogen-containing heterocyclic compound, and medicine containing such compound as effective ingredient